← Browse by Condition
Medical Condition

intracranial aneurysm

Total Trials
4
Recruiting Now
4
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for intracranial aneurysm sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — intracranial aneurysm Clinical Trials

How many clinical trials are currently recruiting for intracranial aneurysm?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for intracranial aneurysm, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for intracranial aneurysm?
intracranial aneurysm research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a intracranial aneurysm clinical trial?
Eligibility criteria for intracranial aneurysm trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Montefiore Medical Center 1 trial
University Hospital, Ghent 1 trial
Centre hospitalier de l'Université de Montréal (CHUM) 1 trial
University Hospital, Geneva 1 trial

Recruiting Clinical Trials

NCT06174727
Recruiting
International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)
Enrollment
5,000 pts
Location
United States, Canad...
Sponsor
Montefiore Medical Center
View Trial →
NCT06588543
Recruiting
Patient-specific Planning of Minimally Invasive Brain Interventions Based on Vascular-hemodynamic Mapping
Enrollment
500 pts
Location
Belgium
Sponsor
University Hospital, Ghent
View Trial →
NCT04155606
Recruiting
Comprehensive Aneurysm Management Trial
Enrollment
2,000 pts
Location
Canada, France, Ital...
Sponsor
Centre hospitalier de l'Univer...
View Trial →
NCT03245866
Recruiting
Swiss Study on Subarachnoid Hemorrhage
Enrollment
5,000 pts
Location
Switzerland
Sponsor
University Hospital, Geneva
View Trial →

Related Conditions

arteriovenous malformations cerebral (1) saccular aneurysm (1) unruptured cerebral aneurysm (1) subarachnoid hemorrhage (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology